Risa Kagan, MD, on why the menopause transition is a critical window for bone loss and how women can preserve bone mass.
|Articles|August 23, 2006
The Halt Procedure - Radio Frequency Ablation of Uterine Fibroids Video
Author(s)Bruce Lee, MD
OBGYN.net Conference Coverage - AAGL 2004
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Risa Kagan, MD, on bone health across a woman's lifetime
2
FAQ: Where do testosterone pellets stand for women?
3
FAQ: What does the evidence show about testosterone in women?
4
HRSA opens $1 million funding to update women's preventive guidelines
5